Planet 13 Holdings (PLNH) Liabilities and Shareholders Equity (2021 - 2026)

Planet 13 Holdings' (PLNH) quarterly Liabilities and Shareholders Equity came in at $146.9 million in Q1 2026, down 27.91% year-on-year from $203.8 million in Q1 2025, and down 3.52% on a QoQ basis from $152.3 million in Q4 2025.

Planet 13 Holdings (PLNH) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

Planet 13 Holdings (PLNH) has 6 years of Liabilities and Shareholders Equity data on file, last reported at $146.9 million in Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 27.91% year-over-year to $146.9 million in Q1 2026; TTM through Mar 2026 was $658.7 million, a 26.48% decrease from a year earlier, with the FY2025 full-year figure at $152.3 million, down 26.34% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $146.9 million, down from $152.3 million in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for PLNH reached as high as $274.0 million in Q1 2022 and fell as low as $146.9 million in Q1 2026.
  • Historically, Liabilities and Shareholders Equity has averaged $204.1 million across 5 years, with a median of $206.7 million in 2023.
  • Across the five-year window, Liabilities and Shareholders Equity slumped 38.46% in 2023 and jumped 49.89% in 2024, its largest moves.
  • Year by year, Liabilities and Shareholders Equity stood at $220.1 million in 2022, then tumbled by 31.04% to $151.7 million in 2023, then soared by 36.24% to $206.7 million in 2024, then dropped by 26.34% to $152.3 million in 2025, then declined by 3.52% to $146.9 million in 2026.
  • Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $146.9 million in Q1 2026, $152.3 million in Q4 2025, and $158.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 43.40 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 40.04 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 15.15 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 98.91 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 6.71 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 69.30 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 36.83 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 4.91 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 13.22 Bn
10 Planet 13 Holdings 39.35 Mn 23.09 Mn 9.41 Mn 146.91 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 146.91 Mn
Dec 31, 2025 152.28 Mn
Sep 30, 2025 158.50 Mn
Jun 30, 2025 200.98 Mn
Mar 31, 2025 203.79 Mn
Dec 31, 2024 206.73 Mn
Sep 30, 2024 242.96 Mn
Jun 30, 2024 242.43 Mn
Mar 31, 2024 157.39 Mn
Dec 31, 2023 151.75 Mn
Sep 30, 2023 162.10 Mn
Jun 30, 2023 206.70 Mn
Mar 31, 2023 211.48 Mn
Dec 31, 2022 220.06 Mn
Sep 30, 2022 263.41 Mn
Jun 30, 2022 268.44 Mn
Mar 31, 2022 274.00 Mn
Dec 31, 2021 213.81 Mn